EXCITING GENETIC DISCOVERIES FUNDED BY APDA

May 6, 2021 In an exciting new study, researchers at the APDA Center for Advanced Research at Brigham and...see more Women’s Hospital studied the genetic changes that increase the rate of progression of Parkinson’s disease (PD). Currently, there are many genes that are associated with an increased risk of developing PD. But once a person has […]

Read More

New Clinical Use for Gocovri

Adamas announced that the Food and Drug Administration (FDA) approved Gocovri for a second indication – as an add-on...see more treatment to carbidopa/levodopa in Parkinson’s disease (PD) patients who are experiencing OFF episodes. Previously, Gocovri was only approved for treatment of Levodopa-induced dyskinesias. You can learn more about managing dyskinesias and OFF episodes in this webinar. […]

Read More

WHAT’S HAPPENING AT APDA

What’s Happening at APDA   Meet the Researchers: Virtual Research Roundtable In February, we hosted a virtual roundtable event...see more (via Zoom), featuring four APDA-funded researchers. Missed it? Don’t worry — you can find the recording in our Educational Video Library at apdaparkinson.org/videos and watch it anytime! Virtual Events — Anywhere, for Anyone! Visit apdaparkinson.org/events to […]

Read More

New technology from Abbott allows for remote programming of DBS device

Abbott, one of the manufacturers of deep brain stimulation (DBS) devices for Parkinson’s disease (PD) recently released NeuroSphereTM Virtual...see more Clinic, a technology that allows for virtual visits between patients and their DBS neurologist and is the first system to allow for remote programming of the DBS device. Currently, a device can be programmed so that […]

Read More